BETRF Stock Price, Chart, Stats & News

BetterLife Pharma Inc.
Save
BetterLife Pharma Inc. (BETRF) does not currently pay a dividend.
33.51M
Market cap
–
Current P/E
–
Forward P/E
BETRF chart
About
Health care
Sector
Biotechnology
Industry
BetterLife Pharma Inc., a biotechnology firm headquartered in Vancouver, Canada, specializes in researching and bringing to market therapeutic compounds designed to address neurological disorders across the globe. The company's core focus involves refining and advancing drug candidates derived from interferon-based technologies, which are intended to leverage the immune system to combat viral infections. Its diverse product pipeline includes BETR-001, targeting conditions such as major depressive disorder, treatment-resistant depression, cluster headaches, and post-traumatic stress disorder.
Similar securities
Based on sector and market capitalization
Report issue





